SWK Holdings Corporation

Congratulations to Journey Medical Corporation on this fantastic milestone! SWK Holdings Corporation is thrilled to support such innovative advancements in dermatology that make a real difference. Here’s to the journey ahead!

We are pleased to provide a portfolio update and announce the dates for our Q3 2024 earnings release and conference call. Read the release here: https://loom.ly/LnvjUYc #SWKHoldings #PortfolioUpdate #EarningsUpdate #HealthcareFinance

Congratulations to our portfolio company, Eton Pharmaceuticals, Inc (Nasdaq: ETON) on their agreement to acquire Increlex®. This strategic move aligns with Eton’s mission to deliver life-changing treatments for patients with ultra-rare conditions. We are proud to support their continued growth and impact in the rare disease community. https://loom.ly/1kMl6B0 #SWKHoldings #EtonPharmaceuticals #RareDiseases #InnovativeFinancing

SWK Holdings (Nasdaq: SWKH) is pleased to announce the purchase of three discrete royalty streams from Relief Therapeutics, Inc. (OTCQB: RLFTF) (“Relief”), for a total consideration of $11 million. The purchase price consisted of $5.75 million paid to Relief at close and $5.25 million to be paid upon achievement of certain milestones. #SWKHoldings #HealthcareInnovation #LifeScience

🛠️ Happy Labour Day from SWK Holdings! Today, we salute the hard work and dedication of workers everywhere who contribute to our success. Enjoy a well-deserved day of rest and relaxation! #LabourDay #SWKHoldings #WorkHardPlayHard

Congratulations to our portfolio company, NeoLight, LLC on reaching this significant milestone. Your hard work and progress are commendable, and SWK looks forward to your continued success. #NeoLight #NeonatalCare #BigNews #200kMilestone#NewbornHealth

Did you catch the quarter end results news last week? Here’s a handy infographic with the highlights or find the entire release here: https://loom.ly/zyiBCek

Find our Q2 Earnings release here: https://loom.ly/zyiBCek #SWKHoldings #HealthcareFinance #LifeSciences #InnovativeFinancing

At SWK Holdings, we partner with healthcare and life sciences companies to create long-term value and help bring lifesaving products to market. Our non-dilutive financing supports high-return activities like new technology acquisition and development. 🔹 Why Choose Us? - Non-Dilutive Financing - Deep Healthcare Expertise - Customized Solutions - Focus on Sub-$50M Opportunities Discover how we can support your growth and innovation. #SWKHoldings #HealthcareFinance #LifeSciences #InnovativeFinancing

What is SWK Holdings? 💡 SWK Holdings Corporation is an innovative, life science-focused, specialty finance company, strategically collaborating with small and mid-sized, commercial-stage healthcare entities. Our unique financing structures offer flexible solutions at an attractive cost of capital, creating long-term value for all our stakeholders. Solutions include: -Structured Debt -Traditional Royalty Monetization -Synthetic Royalty Transactions -Asset Purchases Discover how we can support your healthcare innovations! Contact us today at swkhold.com #SWKHoldings #LifeSciences #HealthcareFinance #MedicalInnovation #NonDilutiveFinancing